Evidence map›Paper›PMID 41818157›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Integrated framework to study genomic surveillance of selective sweeps in multivariants dynamics.

Baltazar Espinoza, Srinivasan Venkatramanan, Andrew Scott Warren, Bryan Leroy Lewis, H Vincent Poor, Simon A Levin, Madhav V Marathe

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Baltazar EspinozaBiocomplexity Institute, University of Virginia, Charlottesville, VA 22904.ORCID 0000-0002-6280-3277
Srinivasan VenkatramananBiocomplexity Institute, University of Virginia, Charlottesville, VA 22904.
Andrew Scott WarrenBiocomplexity Institute, University of Virginia, Charlottesville, VA 22904.
Bryan Leroy LewisBiocomplexity Institute, University of Virginia, Charlottesville, VA 22904.ORCID 0000-0003-0793-6082
H Vincent PoorDepartment of Electrical and Computer Engineering, Princeton University, Princeton, NJ 08544.ORCID 0000-0002-2062-131X
Simon A LevinDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544.ORCID 0000-0002-8216-5639
Madhav V MaratheBiocomplexity Institute, University of Virginia, Charlottesville, VA 22904.ORCID 0000-0003-1653-0658

Funding

Centers for Disease Control and Prevention Foundation (CDCF) 6NU50CK000555-03-01DOD | Defense Threat Reduction Agency (DTRA) HDTRA120F0017DOD | USA | AFC | CCDC | Army Research Office (ARO) W911NF2410126National Science Foundation (NSF) CCF-1917819National Science Foundation (NSF) CCF-1918656National Science Foundation (NSF) DMS-2327710National Science Foundation (NSF) DMS-2327711
6 · The paper itself

Abstract

Pandemics often involve complex transmission dynamics in which epidemiological surveillance is essential but not sufficient for containment, as resurgence may be driven by emerging or imported variants. Rapidly evolving pathogens produce complex disease dynamics driven by emerging variants often differing in their transmissibility, immune escape, and cross-infection. These processes influence individuals' immune life histories, producing highly dynamic immune landscapes that modulate the emergence and dominance of novel variants. We develop an integrated modeling framework that couples multivariant mean-field epidemic modeling with a mechanistic genomic dominance model and a probabilistic surveillance model. This study examines how variant emergence timing, infectiousness advantage, and cross-infection jointly shape epidemic trajectories, immune landscapes, and genomic composition. Our results demonstrate that the dominance dynamics of cocirculating variants correspond to a selective sweep characterized by a system of multilogistic equations driven by population immunity. Moreover, we show that the detection time of newly introduced variants can be accelerated or delayed depending on their emergence conditions and the prevailing variant landscape. Finally, we demonstrate that the effectiveness of response strategies depends critically on the evolving genomic composition of the outbreak, highlighting trade-offs between surveillance sensitivity and intervention timing. We validate our framework by jointly fitting epidemiological and genomic data from the spread of the Ancestral, Alpha, Gamma, and Delta variants in the United States, Denmark, the United Kingdom, and Canada. The results provide a quantitative foundation for linking epidemic dynamics, genomic surveillance, and immune life histories, advancing the development of genomic epidemiology for multivariant outbreaks.

Indexed as

GenomicsPandemicsSARS-CoV-2HumansModels, GeneticbiosurveillanceCOVID-19 variantsepidemic modelinggenomic surveillancevariant detection

Identifiers

PMID41818157
PMCPMC12994164

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.